Global ACTH Deficiency Market Size study, by Type (Acquired, Congenital) by Management (Diagnosis, Treatment) by Related Disorders (Congenital Adrenal Hyperplasia (CAH), Addison’s Disease, Secondary Adrenal Insufficiency, Sheehan’s Syndrome, Others), by End Users (Hospitals, Specialty Clinics Others), by Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) and Regional Forecasts 2021-2027

BIZ4728668
200 Pages
December 2021
Pharmaceuticals

Download Sample Get Discount

Global ACTH Deficiency Market is valued approximately USD XXXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XXXX % over the forecast period 2021-2027. ACTH deficiency arises because of decreased or absent production of adrenocorticotropic hormone (ACTH) by the pituitary gland. A defect in the brain’s hypothalamus or in the pituitary gland may cause the deficiency. Symptoms of ACTH deficiency is similar to Addison disease are loss of appetite, hypotension, weakness, fatigue, nausea, vomiting, and others. The increasing unhealthy lifestyle and rising stress among the population will boost the market growth for ACTH Deficiency. According to American Association of Neurological Surgeons, an estimated 10-15 per million people are affected every year by ACTH deficiency. Also, rising population with unhealthy lifestyle and rising stress level among people is likely to boost the market growth during the forecast period. However, high cost of treatment for ACTD Deficiency would hamper the growth of the market for the forecasted period.

The key regions considered for the global ACTH Deficiency market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of high healthcare expenditure and research and development. Whereas, Europe is also anticipated to exhibit highest CAGR over the forecast period 2021-2027. As the healthcare facilities are expected to grow in the region. Along with this, increased advancement in technology as well as growing healthcare expenditure and rising awareness program for ACTH deficiency will create lucrative growth in the region.

Major market player included in this report are:

Merck & Co., Inc.

Novartis AG

Viatris Inc.

Pfizer Inc.

Hikma Pharmaceutical PLC.

Breckenridge Pharmaceutical, Inc.

Epitope Diagnostics

LabCorp

StrongBridge Biopharma

Bristol Myers Squibb

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Acquired

Congenital

By Management:

Diagnosis

Treatment

By Related Diagnosis:

Congenital Adrenal Hyperplasia (CAH)

Addison’s Disease

Secondary Adrenal Insufficiency

Sheehan’s Syndrome

Others

By End User:

Hospitals

Specialty Clinics Others

By Distribution Channel:

Direct Tender

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global ACTH Deficiency Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. ACTH Deficiency Market, by Region, 2019-2027 (USD Billion)

1.2.2. ACTH Deficiency Market, by Type, 2019-2027 (USD Billion)

1.2.3. ACTH Deficiency Market, by Management, 2019-2027 (USD Billion)

1.2.4. ACTH Deficiency Market, by Related Diagnosis, 2019-2027 (USD Billion)

1.2.5. ACTH Deficiency Market, by End User, 2019-2027 (USD Billion)

1.2.6. ACTH Deficiency Market, by Distribution Channel, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global ACTH Deficiency Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global ACTH Deficiency Market Dynamics

3.1. ACTH Deficiency Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Rising unhealthy lifestyle of consumer

3.1.2. Market Challenges

3.1.2.1. High cost of treatment

3.1.3. Market Opportunities

3.1.3.1. Increasing population with unhealthy lifestyle

Chapter 4. Global ACTH Deficiency Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global ACTH Deficiency Market, by Type

6.1. Market Snapshot

6.2. Global ACTH Deficiency Market by Type, Performance - Potential Analysis

6.3. Global ACTH Deficiency Market Estimates & Forecasts by Type 2018-2027 (USD Billion)

6.4. ACTH Deficiency Market, Sub Segment Analysis

6.4.1. Acquired

6.4.2. Congenital

Chapter 7. Global ACTH Deficiency Market, by Management

7.1. Market Snapshot

7.2. Global ACTH Deficiency Market by Management, Performance - Potential Analysis

7.3. Global ACTH Deficiency Market Estimates & Forecasts by Management 2018-2027 (USD Billion)

7.4. ACTH Deficiency Market, Sub Segment Analysis

7.4.1. Diagnosis

7.4.2. Treatment

Chapter 8. Global ACTH Deficiency Market, by Related Diagnosis

8.1. Market Snapshot

8.2. Global ACTH Deficiency Market by Related Diagnosis, Performance - Potential Analysis

8.3. Global ACTH Deficiency Market Estimates & Forecasts by Related Diagnosis 2018-2027 (USD Billion)

8.4. ACTH Deficiency Market, Sub Segment Analysis

8.4.1. Congenital Adrenal Hyperplasia (CAH)

8.4.2. Addison’s Disease

8.4.3. Secondary Adrenal Insufficiency

8.4.4. Sheehan’s Syndrome

8.4.5. Others

Chapter 9. Global ACTH Deficiency Market, by End User

9.1. Market Snapshot

9.2. Global ACTH Deficiency Market by End User, Performance - Potential Analysis

9.3. Global ACTH Deficiency Market Estimates & Forecasts by End User 2018-2027 (USD Billion)

9.4. ACTH Deficiency Market, Sub Segment Analysis

9.4.1. Hospitals

9.4.2. Specialty Clinics Others

Chapter 10. Global ACTH Deficiency Market, by Distribution Channel

10.1. Market Snapshot

10.2. Global ACTH Deficiency Market by Distribution Channel, Performance - Potential Analysis

10.3. Global ACTH Deficiency Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)

10.4. ACTH Deficiency Market, Sub Segment Analysis

10.4.1. Direct Tender

10.4.2. Hospital Pharmacy

10.4.3. Retail Pharmacy

10.4.4. Online Pharmacy

10.4.5. Others

Chapter 11. Global ACTH Deficiency Market, Regional Analysis

11.1. ACTH Deficiency Market, Regional Market Snapshot

11.2. North America ACTH Deficiency Market

11.2.1. U.S. ACTH Deficiency Market

11.2.1.1. Type breakdown estimates & forecasts, 2018-2027

11.2.1.2. Management breakdown estimates & forecasts, 2018-2027

11.2.1.3. Related Diagnosis breakdown estimates & forecasts, 2018-2027

11.2.1.4. End User breakdown estimates & forecasts, 2018-2027

11.2.1.5. Distribution Channel breakdown estimates & forecasts, 2018-2027

11.2.2. Canada ACTH Deficiency Market

11.3. Europe ACTH Deficiency Market Snapshot

11.3.1. U.K. ACTH Deficiency Market

11.3.2. Germany ACTH Deficiency Market

11.3.3. France ACTH Deficiency Market

11.3.4. Spain ACTH Deficiency Market

11.3.5. Italy ACTH Deficiency Market

11.3.6. Rest of Europe ACTH Deficiency Market

11.4. Asia-Pacific ACTH Deficiency Market Snapshot

11.4.1. China ACTH Deficiency Market

11.4.2. India ACTH Deficiency Market

11.4.3. Japan ACTH Deficiency Market

11.4.4. Australia ACTH Deficiency Market

11.4.5. South Korea ACTH Deficiency Market

11.4.6. Rest of Asia Pacific ACTH Deficiency Market

11.5. Latin America ACTH Deficiency Market Snapshot

11.5.1. Brazil ACTH Deficiency Market

11.5.2. Mexico ACTH Deficiency Market

11.6. Rest of The World ACTH Deficiency Market

Chapter 12. Competitive Intelligence

12.1. Top Market Strategies

12.2. Company Profiles

12.2.1. Merck & Co., Inc.

12.2.1.1. Key Information

12.2.1.2. Overview

12.2.1.3. Financial (Subject to Data Availability)

12.2.1.4. Product Summary

12.2.1.5. Recent Developments

12.2.2. Novartis AG

12.2.3. Viatris Inc.

12.2.4. Pfizer Inc.

12.2.5. Hikma Pharmaceutical PLC.

12.2.6. Breckenridge Pharmaceutical, Inc.

12.2.7. Epitope Diagnostics

12.2.8. LabCorp

12.2.9. StrongBridge Biopharma

12.2.10. Bristol Myers Squibb

Chapter 13. Research Process

13.1. Research Process

13.1.1. Data Mining

13.1.2. Analysis

13.1.3. Market Estimation

13.1.4. Validation

13.1.5. Publishing

13.2. Research Attributes

13.3. Research Assumption

List of Tables

TABLE 1. Global ACTH Deficiency market, report scope

TABLE 2. Global ACTH Deficiency market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global ACTH Deficiency market estimates & forecasts by Type 2018-2027 (USD Billion)

TABLE 4. Global ACTH Deficiency market estimates & forecasts by Management 2018-2027 (USD Billion)

TABLE 5. Global ACTH Deficiency market estimates & forecasts by Related Diagnosis 2018-2027 (USD Billion)

TABLE 6. Global ACTH Deficiency market estimates & forecasts by End User 2018-2027 (USD Billion)

TABLE 7. Global ACTH Deficiency market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)

TABLE 8. Global ACTH Deficiency market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global ACTH Deficiency market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global ACTH Deficiency market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global ACTH Deficiency market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global ACTH Deficiency market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global ACTH Deficiency market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global ACTH Deficiency market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. Global ACTH Deficiency market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. Global ACTH Deficiency market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 17. Global ACTH Deficiency market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. U.S. ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. U.S. ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. U.S. ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. Canada ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. Canada ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. Canada ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. UK ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. UK ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. UK ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. Germany ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. Germany ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. Germany ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. RoE ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. RoE ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. RoE ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. China ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. China ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. China ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. India ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. India ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. India ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. Japan ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. Japan ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Japan ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. RoAPAC ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. RoAPAC ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. RoAPAC ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Brazil ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Brazil ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Brazil ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. Mexico ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. Mexico ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. Mexico ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. RoLA ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. RoLA ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. RoLA ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. Row ACTH Deficiency market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 55. Row ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 56. Row ACTH Deficiency market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 57. List of secondary sources, used in the study of global ACTH Deficiency market

TABLE 58. List of primary sources, used in the study of global ACTH Deficiency market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara